Skip to main content

A 40 years old female presented with chest pain and light headedness on exertion

Aortic Stenosis

A 40 years old female presented with chest pain and light headedness on exertion. Examination showed B.P of 110/90 mmHg, delayed carotid upstroke, double apical impulse, Ejection Systolic Murmur radiating to carotid. ECG is remarkable for Left Ventricular Hypertrophy. Echocardiography revealed critical aortic stenosis with Aortic Valve Area of < 1cm2, Mean Gradient of 30 mmHg and Left Ventricular Ejection Fraction of 60 %.

 


a) How would you differentiate between valvular and sub-valvular aortic stenosis?

b) What are the indications for cardiac catheterization and how will you calculate Aortic Valve Area?

c) What is paradoxical low flow severe Aortic Stenosis and give two reasons for it?

d) What are the class I indications of Aortic Valve Replacement?

e) What is the most likely reason for severe Aortic Stenosis in this woman?





Answers:

a.      Clinical findings of valvular aortic stenosis are presence of ejection click and soft A2. In subvalvular AS there is early diastolic murmur of AR, Heart size is larger,  No ejection click or post stenotic dilatation of aorta.

b.      To further evaluate the severity of AS when the clinical and echocardiographic findings diverge (ACC/AHA Class I Indication), Area calculated by Gorlin Equation.

c.       Paradoxical low-flow (PLF) aortic stenosis is defined by a stroke volume index <35 ml/m2 despite the presence of preserved LV ejection fraction (≥50 %). This entity is typically characterized by pronounced LV concentric remodeling with small LV cavity, impaired LV filling, increased arterial load, and reduced LV longitudinal shortening.

d.      1) symptomatic severe AS, 2) asymptomatic patients with severe AS undergoing coronary artery bypass graft surgery, surgery of the ascending aorta, or surgery of another valve, 3) asymptomatic severe AS with a left ventricular ejection fraction less than 50%, and 4) asymptomatic severe AS with an abnormal exercise test showing symptoms on exercise clearly related to AS


e.      Paradoxical low gradient aortic stenosis

Reference:

1.      Chapter 15, page 246 – Valvular Heart Disease  - Manual of Cardiovascular Medicine Fourth Edition - Brian P. Griffin MD FACC

2.      Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC); European Association for Cardio-Thoracic Surgery (EACTS), Vahanian A, Alfieri O, Andreotti F, Antunes MJ, et al. (2012) Guidelines on the management of valvular heart disease (version 2012). Eur Heart J 33: 2451-2496.



Comments

Popular posts from this blog

Brugada ECG vs Incomplete Right Bundle Branch Block (iRBBB)

Brugada ECG vs Incomplete Right Bundle Branch Block (iRBBB) Why this differentiation matters Brugada pattern is a malignant channelopathy associated with sudden cardiac death, while incomplete RBBB is usually a benign conduction variant. Mislabeling Brugada as iRBBB can be fatal; overcalling iRBBB as Brugada can lead to unnecessary anxiety and ICD implantation. --- 1. Basic Definitions Brugada ECG Pattern Primary repolarization abnormality Genetic sodium-channel disorder Characteristic ST-segment elevation in V1–V3 Risk of ventricular fibrillation and sudden death Incomplete RBBB (iRBBB) Depolarization abnormality Delay in right ventricular conduction Common in healthy individuals Usually asymptomatic and benign --- 2. ECG Morphology: Side-by-Side Comparison QRS Duration Brugada: QRS usually <120 ms iRBBB: QRS <120 ms, but with RBBB morphology --- V1–V2 Pattern (Key Differentiator) Brugada Pseudo-RBBB appearance ST elevation ≥2 mm ST segment is coved or saddleback Terminal QRS bl...

Acute Treatment of Hyperkalemia

Acute Treatment of Hyperkalemia – A Practical, Bedside-Oriented Guide Hyperkalemia is a potentially life-threatening electrolyte abnormality that demands prompt recognition and decisive management. The danger lies not only in the absolute potassium value but in its effects on cardiac conduction, which can rapidly progress to fatal arrhythmias. Acute treatment focuses on three parallel goals: stabilizing the cardiac membrane, shifting potassium into cells, and removing excess potassium from the body. Understanding this stepwise approach helps clinicians act quickly and rationally in emergency settings. Why Hyperkalemia Is Dangerous Potassium plays a key role in maintaining the resting membrane potential of cardiac myocytes. Elevated serum potassium reduces the transmembrane gradient, leading to slowed conduction, ECG changes, ventricular arrhythmias, and asystole. Importantly, ECG changes do not always correlate with potassium levels, so treatment decisions should be based on clinical c...

π˜Όπ™£π™©π™žπ™˜π™€π™–π™œπ™ͺπ™‘π™–π™©π™žπ™€π™£ π˜Όπ™›π™©π™šπ™§ π™Žπ™©π™§π™€π™ π™š

 π˜Όπ™£π™©π™žπ™˜π™€π™–π™œπ™ͺπ™‘π™–π™©π™žπ™€π™£ π˜Όπ™›π™©π™šπ™§ π™Žπ™©π™§π™€π™ π™š in  Patient with AF and acute IS/TIA European Heart Association Guideline recommends: • 1 days after TIA • 3 days after mild stroke • 6 days after moderate stroke • 12 days after severe stroke Early anticoagulation can decrease a risk of recurrent stroke and embolic events but may increase a risk of secondary hemorrhagic transformation of brain infarcts.  The 1-3-6-12-day rule is a known consensus with graded increase in delay of anticoagulation between 1 and 12 days after onset of ischemic stroke or transient ischemic attack(TIA), according to neurological severity based on European expert opinions. However, this rule might be somewhat later than currently used in a real-world practical setting.